Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcos Malumbres

Showing results (1-10 of 183) with videos related to

Pageof 19
Sort By:
Molecular Systems Biology|February 16, 2012
miRNAs versus oncogenes: the power of social networkingMarcos Malumbres
Cancer Cell|June 14, 2011
Oncogene-induced mitotic stress: p53 and pRb get mad tooMarcos Malumbres
Cancer Cell|October 20, 2012
Cell cycle-based therapies move forwardMarcos Malumbres
Advances in Experimental Medicine and Biology|December 14, 2006
Preclinical models for cell cycle-targeted therapiesMarcos Malumbres
Developmental Cell|November 27, 2015
Keeping Order in AnaphaseMarcos Malumbres
Cancer Cell|March 16, 2016
CDK4/6 Inhibitors resTORe Therapeutic Sensitivity in HER²⁺ Breast CancerMarcos Malumbres
Physiological Reviews|July 12, 2011
Physiological relevance of cell cycle kinasesMarcos Malumbres
Genome Biology|September 3, 2014
Cyclin-dependent kinasesMarcos Malumbres
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2018
CDK4/6 Inhibitors: What Is the Best Cocktail?Marcos Malumbres
Molecular Aspects of Medicine|July 10, 2012
miRNAs and cancer: an epigenetics viewMarcos Malumbres
Pageof 19

Showing results (1-10 of 183) with videos related to

Sort By:
Pageof 19
Molecular Systems Biology|February 16, 2012
miRNAs versus oncogenes: the power of social networkingMarcos Malumbres
Cancer Cell|June 14, 2011
Oncogene-induced mitotic stress: p53 and pRb get mad tooMarcos Malumbres
Cancer Cell|October 20, 2012
Cell cycle-based therapies move forwardMarcos Malumbres
Advances in Experimental Medicine and Biology|December 14, 2006
Preclinical models for cell cycle-targeted therapiesMarcos Malumbres
Developmental Cell|November 27, 2015
Keeping Order in AnaphaseMarcos Malumbres
Cancer Cell|March 16, 2016
CDK4/6 Inhibitors resTORe Therapeutic Sensitivity in HER²⁺ Breast CancerMarcos Malumbres
Physiological Reviews|July 12, 2011
Physiological relevance of cell cycle kinasesMarcos Malumbres
Genome Biology|September 3, 2014
Cyclin-dependent kinasesMarcos Malumbres
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2018
CDK4/6 Inhibitors: What Is the Best Cocktail?Marcos Malumbres
Molecular Aspects of Medicine|July 10, 2012
miRNAs and cancer: an epigenetics viewMarcos Malumbres
Pageof 19